“FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS”, EJHSMI, vol. 2, no. 6, pp. 1–11, Jun. 2026, Accessed: Jun. 16, 2026. [Online]. Available: https://eurekaoa.com/index.php/5/article/view/1148